On 2025-05-13, DiaMedica Therapeutics, Inc. (DMAC) announced earnings per share of $-0.18 for the fiscal quarter ending 2025-03-31, meeting the average analyst estimate of $-0.18.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.18 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.18 | $-0.18 |
| 2025-03-17 | 2024-12-31 | $-0.17 | $-0.18 |
| 2024-11-13 | 2024-09-30 | $-0.15 | $-0.15 |
| 2024-08-07 | 2024-06-30 | $-0.16 | $-0.13 |
| 2024-05-08 | 2024-03-31 | $-0.16 | $-0.14 |
| 2024-03-19 | 2023-12-31 | $-0.14 | $-0.14 |
| 2023-11-13 | 2023-09-30 | $-0.14 | $-0.12 |
| 2023-08-14 | 2023-06-30 | $-0.22 | $-0.16 |
| 2023-05-15 | 2023-03-31 | $-0.16 | $-0.20 |
| 2023-03-28 | 2022-12-31 | $-0.14 | $-0.14 |
| 2022-11-09 | 2022-09-30 | $-0.13 | $-0.12 |
| 2022-08-10 | 2022-06-30 | $-0.16 | $-0.13 |
| 2022-05-04 | 2022-03-31 | $-0.20 | $-0.13 |
| 2022-03-14 | 2021-12-31 | $-0.16 | $-0.10 |
| 2021-11-10 | 2021-09-30 | $-0.23 | $-0.18 |
| 2021-08-11 | 2021-06-30 | $-0.19 | $-0.17 |
| 2021-05-05 | 2021-03-31 | $-0.23 | $-0.19 |
| 2021-03-10 | 2020-12-31 | $-0.18 | $-0.23 |
| 2020-11-04 | 2020-09-30 | -- | $-0.19 |
| 2020-08-11 | 2020-06-30 | -- | $-0.17 |
| 2020-05-13 | 2020-03-31 | $-0.28 | $-0.19 |
| 2020-03-23 | 2019-12-31 | $-0.25 | $-0.21 |
| 2019-11-13 | 2019-09-30 | $-0.19 | $-0.20 |
| 2019-08-13 | 2019-06-30 | $-0.28 | $-0.21 |
| 2019-05-13 | 2019-03-31 | $-0.22 | $-0.27 |
| 2019-03-19 | 2018-12-31 | -- | $-0.11 |
| 2018-11-19 | 2018-09-30 | -- | $-0.07 |
| 2018-08-29 | 2018-06-30 | $-0.20 | $-0.40 |
| 2018-05-30 | 2018-03-31 | -- | $-0.20 |